GRI Bio, Inc. (GRI)
1.80
-0.03
(-1.64%)
USD |
NASDAQ |
Nov 12, 16:00
1.80
0.00 (0.00%)
After-Hours: 18:31
GRI Bio Price to Book Value : 0.3828 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 11, 2026 | 0.3892 |
| November 10, 2026 | 0.4019 |
| November 09, 2026 | 0.3636 |
| November 06, 2026 | 0.3998 |
| November 05, 2026 | 0.3296 |
| November 04, 2026 | 0.3041 |
| November 03, 2026 | 0.3275 |
| November 02, 2026 | 0.3105 |
| October 30, 2026 | 0.3254 |
| October 29, 2026 | 0.3339 |
| October 28, 2026 | 0.3456 |
| October 27, 2026 | 0.336 |
| October 26, 2026 | 0.319 |
| October 23, 2026 | 0.3084 |
| October 22, 2026 | 0.302 |
| October 21, 2026 | 0.3126 |
| October 20, 2026 | 0.3105 |
| October 19, 2026 | 0.3084 |
| October 16, 2026 | 0.2935 |
| October 15, 2026 | 0.2977 |
| October 14, 2026 | 0.2977 |
| October 13, 2026 | 0.3296 |
| October 12, 2026 | 0.3339 |
| October 09, 2026 | 0.37 |
| October 08, 2026 | 0.3573 |
| Date | Value |
|---|---|
| October 07, 2026 | 0.3934 |
| October 06, 2026 | 0.404 |
| October 05, 2026 | 0.4062 |
| October 02, 2026 | 0.4168 |
| October 01, 2026 | 0.4168 |
| September 30, 2026 | 0.4104 |
| September 29, 2026 | 0.4253 |
| September 28, 2026 | 0.4466 |
| September 25, 2026 | 0.4359 |
| September 24, 2026 | 0.4445 |
| September 23, 2026 | 0.4572 |
| September 22, 2026 | 0.4359 |
| September 21, 2026 | 0.4126 |
| September 18, 2026 | 0.4104 |
| September 17, 2026 | 0.3913 |
| September 16, 2026 | 0.3849 |
| September 15, 2026 | 0.387 |
| September 14, 2026 | 0.4019 |
| September 11, 2026 | 0.404 |
| September 10, 2026 | 0.4126 |
| September 09, 2026 | 0.3828 |
| September 08, 2026 | 0.4253 |
| September 04, 2026 | 0.6124 |
| September 03, 2026 | 0.487 |
| September 02, 2026 | 0.4253 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.257 |
| Alnylam Pharmaceuticals, Inc. | 5.817 |
| Anika Therapeutics, Inc. | 1.347 |
| Savara, Inc. | 8.976 |
| Vericel Corp. | 7.627 |
Price to Book Value Related Metrics
| Price | 1.80 |
| Earnings Yield | -2.43K% |
| Market Cap | 3.935M |